INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000 | 0.0% | 3,120 | +56.0% | 0.00% | – |
| Q4 2019 | $1,000 | -75.0% | 2,000 | -48.2% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 3,860 | +10.3% | 0.00% | – |
| Q2 2019 | $4,000 | -42.9% | 3,500 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -12.5% | 3,500 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -66.7% | 3,500 | -2.0% | 0.00% | – |
| Q3 2018 | $24,000 | -4.0% | 3,570 | +241.6% | 0.00% | – |
| Q2 2018 | $25,000 | – | 1,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|